ABIOMED, Inc.  

(Public, NASDAQ:ABMD)   Watch this stock  
Find more results for ABMD
77.26
+1.64 (2.17%)
Jul 30 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 74.51 - 78.69
52 week 21.84 - 78.69
Open 75.45
Vol / Avg. 918,472.00/550,757.00
Mkt cap 3.18B
P/E 30.05
Div/yield     -
EPS 2.57
Shares 42.05M
Beta 1.69
Inst. own 96%
Aug 13, 2015
Abiomed Inc Annual Shareholders Meeting (Estimated) - 8:00AM EDT - Add to calendar
Aug 12, 2015
Abiomed Inc Annual Shareholders Meeting - 8:00AM EDT - Add to calendar
Aug 4, 2015
Q1 2016 Abiomed Inc Earnings Call - 8:00AM EDT - Add to calendar
Aug 4, 2015
Q1 2016 Abiomed Inc Earnings Release Add to calendar
Jun 10, 2015
Abiomed Inc at William Blair Annual Growth Stock Conference
Jun 3, 2015
Abiomed Inc at Jefferies Global Healthcare Conference
May 7, 2015
Abiomed Inc at Deutsche Bank Health Care Conference
May 5, 2015
Q4 2015 Abiomed Inc Earnings Release
May 5, 2015
Q4 2015 Abiomed Inc Earnings Call
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2015
Net profit margin 146.36% 49.36%
Operating margin 18.30% 12.45%
EBITD margin - 13.65%
Return on average assets 136.96% 41.81%
Return on average equity 162.77% 49.44%
Employees 589 -
CDP Score - -

Address

22 CHERRY HILL DR
DANVERS, MA 01923-2575
United States - Map
+1-978-7775410 (Phone)
+1-978-7778411 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Abiomed, Inc. is a United States-based company, which provides temporary percutaneous mechanical circulatory support devices and offers a continuum of care to heart failure patients. The Company develops, manufactures and markets products that are designed to enable the heart to rest, heal and recover by improving blood flow to the coronary arteries and end-organs and/or temporarily performing the pumping function of the heart. Its products include Impella 2.5, which is a percutaneous micro heart pump with an integrated motor and sensor; Impella CP, which is used by interventional cardiologists to support patients in the cath lab; Impella RP, which is a percutaneous catheter-based axial flow pump that allows over four liters of flow per minute; Impella LD and Impella 5.0, which are percutaneous micro heart pumps with integrated motors and sensors used in the heart surgery suite, and AB5000, which is a circulatory support system that supports acute heart failure patients in shock.

Officers and directors

Michael R. Minogue Chairman of the Board, President, Chief Executive Officer
Age: 48
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Michael Tomsicek Chief Financial Officer, Vice President, Treasurer
Age: 49
Bio & Compensation  - Reuters
David M. Weber Chief Operating Officer
Age: 53
Bio & Compensation  - Reuters
William J. Bolt Senior Vice President - Global Product Operations
Age: 63
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Andrew J. Greenfield Vice President, General Manager - Global Marketing
Age: 42
Bio & Compensation  - Reuters
Michael G. Howley Vice President, General Manager - Global Sales and Marketing
Age: 51
Bio & Compensation  - Reuters
Ingrid Goldberg Director - Investor Relations
Bio & Compensation  - Reuters
Dorothy E. Puhy Lead Independent Director
Age: 63
Bio & Compensation  - Reuters
W. Gerald Gerald Austen M.D. Independent Director
Age: 85
Bio & Compensation  - Reuters
Louis E. Lataif Independent Director
Age: 76
Bio & Compensation  - Reuters